innovative platform technology

Innovative Technology Platform

Entera's innovative technology enables oral drug delivery of large molecules

27163516 pills

Pipeline of Drug Development

Entera conducts clinical trials of three oral drugs based on a proven active compound

27163516 brain green

Experienced Management Team

The managers of Entera have more than 50 years of experience in drug development

December 17, 2014 – Mr. Gerald M. Lieberman, a former President and Chief Operating Officer at Alliance Bernstein L.P. (until 2009), was appointed to Entera’s board of directors. Mr. Lieberman brings to Entera many years of experience as an executive in leading financial services companies and provides finance, risk management and operating expertise.